Literature DB >> 17977608

The effect of antagonization of orexin 1 receptors in CA1 and dentate gyrus regions on memory processing in passive avoidance task.

Esmaeil Akbari1, Fereshteh Motamedi, Nasser Naghdi, Maryam Noorbakhshnia.   

Abstract

The hippocampal formation plays an essential role in associative learning like passive avoidance (PA) learning. It has been shown; orexin-containing terminals and orexin receptors densely are distributed in the hippocampal formation. We have previously demonstrated that antagonization of orexin 1 receptor (OX1R) in CA1 region of hippocampus and dentate gyrus (DG) impaired spatial memory processing. Although, there are few studies concerning function of orexinergic system on memory processing in PA task, but there is no study about physiological function of OX1R on this process. To address this, the OX1R antagonist, SB-334867-A, was injected into DG or CA1 regions of hippocampus and evaluated the influence of OX1R antagonization on acquisition, consolidation and retrieval in PA task. Our results show that, SB-334867-A administration into CA1 region impaired memory retrieval but not PA acquisition and consolidation. However, SB-334867-A administration into DG region impaired acquisition and consolidation but not PA memory retrieval. Therefore, it seems that endogenous orexins play an important role in learning and memory in the rat through OX1Rs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977608     DOI: 10.1016/j.bbr.2007.09.019

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  25 in total

1.  Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats.

Authors:  Yonghui Li; Sa Li; Chuguang Wei; Huiying Wang; Nan Sui; Gilbert J Kirouac
Journal:  Psychopharmacology (Berl)       Date:  2010-07-20       Impact factor: 4.530

2.  Hippocampal SSTR4 somatostatin receptors control the selection of memory strategies.

Authors:  François Gastambide; Cécile Viollet; Gabriel Lepousez; Jacques Epelbaum; Jean-Louis Guillou
Journal:  Psychopharmacology (Berl)       Date:  2008-06-03       Impact factor: 4.530

Review 3.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  Aging-related alterations in orexin/hypocretin modulation of septo-hippocampal amino acid neurotransmission.

Authors:  E M Stanley; J R Fadel
Journal:  Neuroscience       Date:  2011-08-22       Impact factor: 3.590

Review 5.  Food for thought: the role of appetitive peptides in age-related cognitive decline.

Authors:  Jim R Fadel; Corinne G Jolivalt; Lawrence P Reagan
Journal:  Ageing Res Rev       Date:  2013-02-13       Impact factor: 10.895

6.  Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system.

Authors:  Emily M Stanley; Jim Fadel
Journal:  Synapse       Date:  2012-02-15       Impact factor: 2.562

7.  The Role of Orexin Signaling in the Ventral Tegmental Area and Central Amygdala in Modulating Binge-Like Ethanol Drinking Behavior.

Authors:  Jeffrey J Olney; Montserrat Navarro; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2017-02-09       Impact factor: 3.455

8.  Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement.

Authors:  Ruth Sharf; Maysa Sarhan; Catherine E Brayton; Douglas J Guarnieri; Jane R Taylor; Ralph J DiLeone
Journal:  Biol Psychiatry       Date:  2010-02-26       Impact factor: 13.382

9.  Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats.

Authors:  Karen E Boschen; Jim R Fadel; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2009-07-03       Impact factor: 4.530

10.  Orexin/hypocretin receptor 1 signaling mediates Pavlovian cue-food conditioning and extinction.

Authors:  Sara E Keefer; Sindy Cole; Gorica D Petrovich
Journal:  Physiol Behav       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.